Close
ACHEMA MIDDLE EAST 2026
LogiPharma 2026

Projects

      Arzerra (Ofatumumab) for Treatment of Chronic Lymphocytic Leukaemia (CLL)

      Americas
      Arzerra (ofatumumab) is the first-line drug approved for the treatment of chronic lymphocytic leukaemia (CLL). The drug is developed and marketed by GlaxoSmithKline (GSK)...

      Afrezza – Mealtime Insulin Therapy for Diabetes

      Americas
      Afrezza is a rapid-acting insulin therapy indicated for controlling hyperglycaemia in adult patients with type 1 and type 2 diabetes mellitus. The drug is...

      Shire to Establish Rare Disease Innovation Hub in Cambridge, Mass.

      Americas
      Shire plc announced that it will expand its operations in Cambridge, Massachusetts, establishing a rare disease innovation hub and increasing its footprint in the...

      PCI Services Expanding of Cryogenic Storage Facilities at our Rockford, IL Site

      Americas
      PCI Services are pleased to announce that we are extending our current Cryogenic storage capabilities to our Rockford , Illinois operations, complementing the specialized...

      WUXI BIOLOGICS and PRIMA sign MOU and Announce Strategic Development and Manufacturing Partnership

      Americas
      Prima BioMed Ltd and WuXi Biologics ,a WuXi AppTec group company, and a leading open-access R&D capability and technology platform company dedicated to expedite...

      Amri Announces Strategic Alliance To Advance Mass Spectrometry Capabilities For Drug Discovery

      Americas
      AMRI , a global contract research and manufacturing organization working to improve patient outcomes and quality of life, has entered an alliance with Bruker...

      Amgen to Expand U.S. Manufacturing with $650M Investment

      Americas
      Amgen has announced a $650 million expansion of its U.S. manufacturing facilities, a development that will create almost 750 new positions. The expansion will...

      Subscribe Our Newsletter

      White Papers

      The Future of Digital Health

      Whitepapers 0
      The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....

      Five Best Practices to Deliver Exceptional Multichannel Experiences

      Whitepapers 0
      A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...

      The Impact and Use of Social Media in Pharmacovigilance

      Whitepapers 0
      Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...

      About us

      Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

      System

      Resources

      Subscribe

      © 2025 Copyright © Valuemediaservices 2025 All rights reserved.